Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Axicabtagene Ciloleucel +2 More for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 2
Nashville, Tennessee
This trial is looking at the efficacy of axicabtagene ciloleucel in participants with high-risk large B-cell lymphoma. Participants who received the infusion will be followed for 15 years to assess efficacy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.